Detalhe da pesquisa
1.
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
Cephalalgia
; 41(3): 340-352, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33143451
2.
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study.
Cephalalgia
; 41(3): 294-304, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33541117
3.
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.
Hum Psychopharmacol
; 35(5): e2732, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32449213
4.
Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.
Cephalalgia
; 39(8): 957-966, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31166697
5.
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Headache
; 59(10): 1788-1801, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31529622
6.
Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant.
Headache
; 60(8): 1793-1796, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32700321
7.
Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
J Alzheimers Dis
; 2024 Jun 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38875031
8.
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials.
CNS Drugs
; 36(7): 771-783, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35779194
9.
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease.
Clin Ther
; 44(11): 1449-1462, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36210219
10.
Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies.
Neurol Ther
; 9(2): 459-471, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32447545